EMA Re-Examines Decisions On Prestige’s Trastuzumab And Synchron Studies

CHMP Rejection Of Herceptin Biosimilar And Suspension Of Generics To Be Reviewed

 
• By David Wallace
  
EMA
The EMA will review a pair of CHMP decisions following re-examination requests
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products